搜尋





搜尋





市場行情
/
股票
/
pmcb
/

PharmaCyte Biotech Inc

PMCB

添加自選

0.584USD

-0.016-2.67%

收盤 07-31 16:00（美東）報價延遲15分鐘

6.27M總市值

虧損本益比TTM

PharmaCyte Biotech Inc

0.584

-0.016-2.67%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

PMCB 利潤表

您可以在這裡找到PharmaCyte Biotech Inc的年度或季度收入報告，以深入了解PharmaCyte Biotech Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q4

FY2026Q3

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q4

FY2015Q3

FY2015Q2

FY2015Q1

FY2014Q4

FY2014Q3

FY2014Q2

FY2014Q1

FY2013Q4

FY2013Q3

FY2013Q2

FY2013Q1

FY2012Q3

FY2012Q2

FY2012Q1

營業總收入

--0.00

----

--0.00

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

-68.32%6.29K

-66.47%6.63K

--20.27K

--19.84K

--19.76K

營業收入

--0.00

----

--0.00

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

-68.32%6.29K

-66.47%6.63K

--20.27K

--19.84K

--19.76K

主營業務成本

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

59.38%9.62K

-100.00%0.00

--2.21K

--6.04K

--15.68K

營業費用

-7.68%961.83K

120.58%2.12M

24.41%1.38M

-33.15%848.30K

-10.66%1.04M

-48.62%960.25K

-21.53%1.11M

-38.86%1.27M

29.11%1.17M

20.35%1.87M

-39.21%1.41M

23.49%2.08M

-40.09%903.28K

81.40%1.55M

130.74%2.32M

64.23%1.68M

45.68%1.51M

13.12%856.12K

5.83%1.00M

16.07%1.02M

38.01%1.03M

-13.53%756.85K

-11.02%949.51K

-22.26%881.68K

-36.04%749.89K

29.42%875.31K

2.95%1.07M

-6.69%1.13M

-19.04%1.17M

-66.69%676.35K

-42.87%1.04M

-28.02%1.22M

25.42%1.45M

58.40%2.03M

86.24%1.81M

63.70%1.69M

2.09%1.15M

-28.47%1.28M

-40.45%974.20K

-31.89%1.03M

-71.56%1.13M

23.04%1.79M

-73.81%1.64M

-4.35%1.51M

-75.83%3.98M

113.86%1.46M

1292.30%6.25M

13.03%1.58M

3513.64%16.45M

99.82%681.08K

26.33%448.57K

156.81%1.40M

--455.19K

-20.78%340.84K

-16.17%355.08K

-18.88%545.41K

--430.25K

--423.57K

--672.36K

研發費用

-51.12%61.95K

-21.22%93.11K

44.75%141.09K

-0.89%95.16K

34.56%126.73K

-6.74%118.20K

18.82%97.47K

-8.10%96.02K

9.68%94.18K

179.19%126.73K

-53.91%82.03K

-34.40%104.48K

-66.20%85.87K

-71.28%45.39K

31.63%178.00K

10.90%159.27K

-20.67%254.06K

-9.22%158.04K

-10.64%135.22K

-46.92%143.61K

227.96%320.27K

53.66%174.09K

743.44%151.31K

274.08%270.57K

442.14%97.66K

91.56%113.30K

-84.41%17.94K

-72.99%72.33K

-92.86%18.01K

-92.63%59.14K

-77.67%115.10K

-37.38%267.79K

45.09%252.12K

38.44%802.56K

103.12%515.46K

144.38%427.67K

-26.86%173.76K

1.00%579.72K

-42.29%253.77K

12.41%175.00K

-91.68%237.57K

109.63%573.98K

26.44%439.71K

--155.68K

782.64%2.86M

--273.80K

--347.76K

----

--323.50K

--0.00

----

折舊攤銷及損耗

----

--0.00

----

--0.00

----

--0.00

-100.00%0.00

--8.28K

--7.86K

--8.52K

其他營業費用

----

---2.53M

----

營業利潤

7.68%-961.83K

-120.58%-2.12M

-24.41%-1.38M

33.15%-848.30K

10.66%-1.04M

48.62%-960.25K

21.53%-1.11M

38.86%-1.27M

-29.11%-1.17M

-20.35%-1.87M

39.21%-1.41M

-23.49%-2.08M

40.09%-903.28K

-81.40%-1.55M

-130.74%-2.32M

-64.23%-1.68M

-45.68%-1.51M

-13.12%-856.12K

-5.83%-1.00M

-16.07%-1.02M

-38.01%-1.03M

13.53%-756.85K

11.02%-949.51K

22.26%-881.68K

36.04%-749.89K

-29.42%-875.31K

-2.95%-1.07M

6.69%-1.13M

19.04%-1.17M

66.69%-676.35K

42.87%-1.04M

28.02%-1.22M

-25.42%-1.45M

-58.40%-2.03M

-86.24%-1.81M

-63.70%-1.69M

-2.09%-1.15M

28.47%-1.28M

40.45%-974.20K

31.89%-1.03M

71.56%-1.13M

-23.04%-1.79M

73.81%-1.64M

4.35%-1.51M

75.83%-3.98M

-113.86%-1.46M

-1292.30%-6.25M

-13.03%-1.58M

-3513.64%-16.45M

-99.82%-681.08K

-28.61%-448.57K

-159.97%-1.40M

---455.19K

16.86%-340.84K

13.61%-348.80K

17.44%-538.79K

---409.98K

---403.73K

---652.60K

淨非營業利息收入（費用）

利息收入

-65.85%78.50K

-9.79%230.67K

-46.05%206.39K

-60.22%217.79K

-69.23%229.88K

-71.00%255.69K

-57.22%382.56K

-37.50%547.43K

3.34%747.10K

38.65%881.66K

103.61%894.18K

527.86%875.88K

735.12%722.94K

1298.82%635.89K

1614.24%439.17K

--139.50K

--86.57K

--45.46K

--25.62K

----

-85.23%22.00

334.19%508.00

--988.00

----

--149.00

--117.00

----

--4.65K

----

--0.00

----

利息費用

----

--0.00

-100.00%0.00

-93.80%42.00

20.36%467.00

129.58%1.04K

--249.00

--677.00

--388.00

--453.00

----

-100.00%0.00

102.09%483.00

3.97%131.00

83.51%356.00

-9.97%569.00

12.21%239.00

-91.70%126.00

-90.64%194.00

-76.17%632.00

--213.00

-59.65%1.52K

-42.51%2.07K

--2.65K

----

--3.76K

-94.64%3.61K

----

--41.75K

----

--67.27K

----

出售證券收益

--380.68K

--0.00

--2.09M

-100.00%0.00

--0.00

--21.40M

----

特殊收入（費用）

-126.68%-3.89M

212.59%2.63M

-824.52%-6.89M

-381.35%-7.73M

363.76%14.58M

-735.97%-2.34M

-122.53%-745.00K

238.61%2.75M

--3.14M

--368.00K

--3.31M

---1.98M

----

-100.00%0.00

----

--75.98K

----

-100.00%0.00

--0.00

-100.00%0.00

----

6021.21%1.15M

-100.00%0.00

141.94%2.18M

100.00%0.00

-111.81%-19.50K

805.54%225.92K

-15758.59%-5.21M

-4637.54%-3.26M

--165.12K

-118.41%-32.02K

--33.25K

--71.74K

--173.96K

--0.00

-固定資產出售收益

100.00%0.00

----

-28.42%-2.02M

----

---1.57M

----

其他非經營性收入（費用）

-16.81%-132.00

-58.00%-632.00

-136401.69%-1.45M

36.32%-121.00

-100.06%-113.00

-58.10%-400.00

-38.82%-1.06K

89.72%-190.00

259.23%194.01K

-100.17%-253.00

27.69%-765.00

52.66%-1.85K

3533.44%54.01K

24379.05%152.96K

-120.42%-1.06K

-144.13%-3.91K

---1.57K

---630.00

---480.00

14.89%-1.60K

100.00%0.00

--0.00

---1.88K

-100.12%-40.00

----

-78.11%33.40K

----

--152.59K

----

-100.00%0.00

100.00%0.00

--9.03K

--1.18K

--430.00

---95.00

----

--0.00

-100.00%0.00

--0.00

--2.59K

--0.00

稅前利潤

-137.39%-4.39M

124.52%746.86K

-404.78%-7.42M

-135.69%-8.36M

772.47%11.75M

-391.55%-3.05M

-152.67%-1.47M

835.76%23.42M

1165.95%1.35M

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

-48.20%-1.42M

-7.16%-811.29K

-3.11%-979.75K

-16.00%-1.03M

-27.94%-960.00K

13.51%-757.10K

10.96%-950.19K

22.06%-883.94K

34.12%-750.38K

-29.42%-875.31K

-2.95%-1.07M

6.69%-1.13M

12.08%-1.14M

66.69%-676.35K

42.87%-1.04M

28.02%-1.22M

-12.16%-1.30M

-58.38%-2.03M

-86.17%-1.81M

-63.61%-1.69M

-2.94%-1.16M

28.42%-1.28M

40.42%-974.55K

31.89%-1.03M

60.23%-1.12M

-22.84%-1.79M

59.75%-1.64M

4.40%-1.52M

82.87%-2.82M

-217.82%-1.46M

28.18%-4.06M

66.04%-1.58M

-4934.28%-16.47M

-21.74%-458.77K

-1378.01%-5.66M

-814.05%-4.67M

---327.17K

-38.66%-376.84K

12.43%-382.82K

25.58%-510.52K

---271.78K

---437.15K

---686.02K

所得稅

--0.00

----

--0.00

----

--0.00

----

--0.00

----

--0.00

----

--0.00

----

--0.00

----

--0.00

除稅後利潤

-137.39%-4.39M

124.52%746.86K

-404.78%-7.42M

-135.69%-8.36M

772.47%11.75M

-391.55%-3.05M

-152.67%-1.47M

835.76%23.42M

1165.95%1.35M

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

-48.20%-1.42M

-7.16%-811.29K

-3.11%-979.75K

-16.00%-1.03M

-27.94%-960.00K

13.51%-757.10K

10.96%-950.19K

22.06%-883.94K

34.12%-750.38K

-29.42%-875.31K

-2.95%-1.07M

6.69%-1.13M

12.08%-1.14M

66.69%-676.35K

42.87%-1.04M

28.02%-1.22M

-12.16%-1.30M

-58.38%-2.03M

-86.17%-1.81M

-63.61%-1.69M

-2.94%-1.16M

28.42%-1.28M

40.42%-974.55K

31.89%-1.03M

60.23%-1.12M

-22.84%-1.79M

59.75%-1.64M

4.40%-1.52M

82.87%-2.82M

-217.82%-1.46M

28.18%-4.06M

66.04%-1.58M

-4934.28%-16.47M

-21.74%-458.77K

-1378.01%-5.66M

-814.05%-4.67M

---327.17K

-38.66%-376.84K

12.43%-382.82K

25.58%-510.52K

---271.78K

---437.15K

---686.02K

持續經營利潤

-137.39%-4.39M

124.52%746.86K

-404.78%-7.42M

-135.69%-8.36M

772.47%11.75M

-391.55%-3.05M

-152.67%-1.47M

835.76%23.42M

1165.95%1.35M

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

-48.20%-1.42M

-7.16%-811.29K

-3.11%-979.75K

-16.00%-1.03M

-27.94%-960.00K

13.51%-757.10K

10.96%-950.19K

22.06%-883.94K

34.12%-750.38K

-29.42%-875.31K

-2.95%-1.07M

6.69%-1.13M

12.08%-1.14M

66.69%-676.35K

42.87%-1.04M

28.02%-1.22M

-12.16%-1.30M

-58.38%-2.03M

-86.17%-1.81M

-63.61%-1.69M

-2.94%-1.16M

28.42%-1.28M

40.42%-974.55K

31.89%-1.03M

60.23%-1.12M

-22.84%-1.79M

59.75%-1.64M

4.40%-1.52M

82.87%-2.82M

-217.82%-1.46M

28.18%-4.06M

66.04%-1.58M

-4934.28%-16.47M

-21.74%-458.77K

-1378.01%-5.66M

-814.05%-4.67M

---327.17K

-38.66%-376.84K

12.43%-382.82K

25.58%-510.52K

---271.78K

---437.15K

---686.02K

反常淨利潤

----

--0.00

----

--0.00

----

歸属于母公司的淨利潤

-144.93%-4.87M

48.90%-1.56M

-184.45%-8.42M

-155.89%-8.36M

526.94%10.85M

45.81%-3.05M

-31.03%-2.96M

320.77%14.96M

-1910.91%-2.54M

-635.49%-5.62M

-20.08%-2.26M

-338.52%-6.78M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

-48.20%-1.42M

-7.16%-811.29K

-3.11%-979.75K

-16.00%-1.03M

-27.94%-960.00K

13.51%-757.10K

10.96%-950.19K

22.06%-883.94K

34.12%-750.38K

-29.42%-875.31K

-2.95%-1.07M

6.69%-1.13M

12.08%-1.14M

66.69%-676.35K

42.87%-1.04M

28.02%-1.22M

-12.16%-1.30M

-58.38%-2.03M

-86.17%-1.81M

-63.61%-1.69M

-2.94%-1.16M

28.42%-1.28M

40.42%-974.55K

31.89%-1.03M

60.23%-1.12M

-22.84%-1.79M

59.75%-1.64M

4.40%-1.52M

82.87%-2.82M

-217.82%-1.46M

28.18%-4.06M

66.04%-1.58M

-4934.28%-16.47M

-21.74%-458.77K

-1378.01%-5.66M

-814.05%-4.67M

---327.17K

-38.66%-376.84K

12.43%-382.82K

25.58%-510.52K

---271.78K

---437.15K

---686.02K

優先股派息

-46.85%479.97K

--2.30M

-32.95%998.63K

-100.00%0.00

-76.77%903.05K

-100.00%0.00

-70.50%1.49M

135.64%8.46M

--3.89M

--5.00M

--5.05M

--3.59M

----

歸屬普通股東的淨利潤

-144.93%-4.87M

48.90%-1.56M

-184.45%-8.42M

-155.89%-8.36M

526.94%10.85M

45.81%-3.05M

-31.03%-2.96M

320.77%14.96M

-1910.91%-2.54M

-635.49%-5.62M

-20.08%-2.26M

-338.52%-6.78M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

-48.20%-1.42M

-7.16%-811.29K

-3.11%-979.75K

-16.00%-1.03M

-27.94%-960.00K

13.51%-757.10K

10.96%-950.19K

22.06%-883.94K

34.12%-750.38K

-29.42%-875.31K

-2.95%-1.07M

6.69%-1.13M

12.08%-1.14M

66.69%-676.35K

42.87%-1.04M

28.02%-1.22M

-12.16%-1.30M

-58.38%-2.03M

-86.17%-1.81M

-63.61%-1.69M

-2.94%-1.16M

28.42%-1.28M

40.42%-974.55K

31.89%-1.03M

60.23%-1.12M

-22.84%-1.79M

59.75%-1.64M

4.40%-1.52M

82.87%-2.82M

-217.82%-1.46M

28.18%-4.06M

66.04%-1.58M

-4934.28%-16.47M

-21.74%-458.77K

-1378.01%-5.66M

-814.05%-4.67M

---327.17K

-38.66%-376.84K

12.43%-382.82K

25.58%-510.52K

---271.78K

---437.15K

---686.02K

基本每股收益

-128.90%-0.46

61.60%-0.17

-219.66%-1.24

-164.70%-1.23

620.06%1.58

32.99%-0.44

-50.39%-0.39

453.67%1.90

-4185.21%-0.30

-1523.09%-0.65

-182.01%-0.26

-624.86%-0.54

89.28%-0.01

-7.45%-0.04

-61.85%-0.09

88.49%-0.07

89.12%-0.07

92.20%-0.04

90.82%-0.06

18.94%-0.64

15.43%-0.61

50.00%-0.48

49.38%-0.61

43.62%-0.80

51.52%-0.72

-6.67%-0.96

15.62%-1.22

18.97%-1.41

23.85%-1.48

71.15%-0.90

48.39%-1.44

36.26%-1.74

0.76%-1.95

-39.60%-3.12

-61.74%-2.79

-38.93%-2.73

10.27%-1.96

37.13%-2.23

47.49%-1.73

36.10%-1.96

63.32%-2.19

-13.40%-3.56

62.11%-3.29

9.29%-3.08

83.85%-5.97

-175.00%-3.13

44.69%-8.67

74.72%-3.39

-3421.43%-36.98

10.59%-1.14

-1074.16%-15.68

-632.79%-13.41

---1.05

-16.44%-1.27

23.93%-1.33

34.76%-1.83

---1.09

---1.75

---2.81

稀釋每股收益

-128.90%-0.46

61.60%-0.17

-219.66%-1.24

-164.70%-1.23

620.06%1.58

32.99%-0.44

-50.39%-0.39

453.67%1.90

-4185.21%-0.30

-1523.09%-0.65

-182.01%-0.26

-624.86%-0.54

89.28%-0.01

-7.45%-0.04

-61.85%-0.09

88.49%-0.07

89.12%-0.07

92.20%-0.04

90.82%-0.06

18.94%-0.64

15.43%-0.61

50.00%-0.48

49.38%-0.61

43.62%-0.80

51.52%-0.72

-6.67%-0.96

15.62%-1.22

18.97%-1.41

23.85%-1.48

71.15%-0.90

48.39%-1.44

36.26%-1.74

0.76%-1.95

-39.60%-3.12

-61.74%-2.79

-38.93%-2.73

10.27%-1.96

37.13%-2.23

47.49%-1.73

36.10%-1.96

63.32%-2.19

-13.40%-3.56

62.11%-3.29

9.29%-3.08

83.85%-5.97

-175.00%-3.13

44.69%-8.67

74.72%-3.39

-3421.43%-36.98

10.59%-1.14

-1074.16%-15.68

-632.79%-13.41

---1.05

-16.44%-1.27

23.93%-1.33

34.76%-1.83

---1.09

---1.75

---2.81

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 PharmaCyte Biotech Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 PMCB 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

PharmaCyte Biotech Inc 全年的淨利潤是多少？



PharmaCyte Biotech Inc 2025 財年淨利潤為 -23.21M。

PharmaCyte Biotech Inc 上一季度的淨利潤是多少？



PharmaCyte Biotech Inc 最近一個季度的淨利潤為 -4.87M。

PharmaCyte Biotech Inc 年度營業利潤是多少？



PharmaCyte Biotech Inc 2025 財年的營業利潤為 -4.38M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。